Answer
Efavirenz/emtricitabine/tenofovir disoproxil should not be used during breastfeeding because efavirenz, emtricitabine and tenofovir enter human milk, their effects on newborns/infants are insufficiently known, and infant risk cannot be excluded; women with HIV are also advised not to breastfeed to avoid HIV transmission.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Dr. Reddy's 600 mg/200 mg/245 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked